#1 Clinical Trials Search in Europe

Azithromycin Dihydrate

This article explores the use of Azithromycin Dihydrate in clinical trials for various medical conditions. Azithromycin is an antibiotic medication that has been studied for its potential benefits in treating lung transplant complications, eye infections, and inflammatory bowel diseases. We’ll examine the key findings from these trials and discuss how this drug may impact patient care in different medical fields.

Table of Contents

What is Azithromycin Dihydrate?

Azithromycin Dihydrate is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called macrolide antibiotics. Azithromycin works by stopping the growth of bacteria[1]. This medication is also known by other names, including:

  • Azithromycin 250 mg
  • ZTM250
  • Zitromax TM (ATC J01FA10)[2]

Medical Uses

Azithromycin Dihydrate is used to treat a wide range of bacterial infections, including:

  • Respiratory infections: Such as pneumonia and bronchitis[2]
  • Skin infections: Including bacterial skin infections in newborns[3]
  • Sexually transmitted infections: Like chlamydia[3]
  • Ear infections: In both children and adults[3]
  • Prevention of infections: In some cases, it’s used to prevent infections in newborns and mothers after childbirth[3]

How It’s Administered

Azithromycin Dihydrate is typically taken orally in tablet or liquid form. The dosage and duration of treatment depend on the specific condition being treated. Some common administration methods include:

  • Single dose: For some infections, a single large dose (e.g., 2 grams) may be given[3]
  • Multiple day course: Often prescribed for 3-5 days, with varying dosages[4]
  • Nebulized form: In some research settings, it’s being studied as a nebulized (inhaled) medication for certain lung conditions[5]

Effectiveness

Azithromycin Dihydrate has been shown to be effective in treating various bacterial infections. Some key points about its effectiveness include:

  • It can reduce bacterial carriage (presence of bacteria) in both mothers and newborns when given during labor[3]
  • Studies have shown it may help prevent neonatal sepsis (a severe blood infection in newborns) and reduce neonatal mortality when given to mothers during childbirth[3]
  • It’s being researched for its potential in preventing and treating bronchopulmonary dysplasia, a lung condition in premature infants[5]

Potential Side Effects

Like all medications, Azithromycin Dihydrate can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Abdominal pain
  • Headache

More serious side effects, though rare, can include:

  • Allergic reactions: Such as rash, itching, or swelling
  • Liver problems: Symptoms may include yellowing of the skin or eyes
  • Heart rhythm changes: In some cases, it may affect heart rhythm[6]

Use in Special Populations

Azithromycin Dihydrate is being studied for use in several special populations:

  • Pregnant women: Research is ongoing to determine its safety and effectiveness when given during labor to prevent infections in newborns[3]
  • Newborns and infants: Studies are investigating its use in preventing and treating certain conditions in very young children[5]
  • Patients with lung conditions: It’s being studied for use in conditions like bronchopulmonary dysplasia and post-lung transplant complications[2][5]

Ongoing Research

Azithromycin Dihydrate is the subject of ongoing research in several areas:

  • Prevention of neonatal sepsis: Large-scale studies are investigating its potential to prevent serious infections in newborns when given to mothers during childbirth[3]
  • Treatment of lung conditions: Research is exploring its use in treating and preventing various lung conditions, particularly in premature infants and lung transplant recipients[2][5]
  • Pharmacokinetics: Studies are examining how the drug is processed in the body, including differences based on ethnicity and genetic factors[6]
  • Combination therapies: Research is investigating its use in combination with other medications for various conditions[7]

It’s important to note that while these research areas are promising, many are still in the experimental stage and not yet approved for general use. Always consult with your healthcare provider about the most appropriate treatments for your specific condition.

Aspect Details
Medical Conditions Studied Lung transplant complications (lymphocytic bronchiolitis, bronchiolitis obliterans syndrome), eye infections, Crohn’s disease
Administration Methods Oral tablets, eye drops
Dosages Used Varies by study: 250mg-600mg for oral tablets, 0.5%-1.5% for eye drops
Primary Outcomes Measured Lung function (FEV1), histology changes, bioequivalence, tear concentrations, anti-drug antibody development
Potential Benefits Reduced inflammation, prevention of bronchiolitis obliterans syndrome, improved survival rates in lung transplant patients, treatment of eye infections, reduction of immunogenicity in Crohn’s disease patients
Study Designs Randomized controlled trials, crossover studies, open-label studies

FAQ

  • What is Azithromycin Dihydrate? Azithromycin Dihydrate is an antibiotic medication that belongs to the macrolide class. It is used to treat various bacterial infections and has been studied for its potential benefits in different medical conditions.
  • In which medical conditions is Azithromycin being studied? Azithromycin is being studied in clinical trials for conditions such as lung transplant complications (like lymphocytic bronchiolitis and bronchiolitis obliterans syndrome), eye infections, and inflammatory bowel diseases like Crohn's disease.
  • How is Azithromycin administered in these trials? The administration of Azithromycin varies depending on the study. In some trials, it is given orally as tablets, while in others, it may be administered as eye drops. The dosage and duration of treatment also vary based on the specific condition being studied.
  • What are some potential benefits of Azithromycin in lung transplant patients? In lung transplant patients, Azithromycin is being studied for its potential to reduce inflammation, prevent bronchiolitis obliterans syndrome, and improve overall survival rates. It may also help in treating lymphocytic bronchiolitis, which is a risk factor for chronic rejection after lung transplantation.
  • Are there any side effects associated with Azithromycin use in these trials? While specific side effects are not mentioned in the provided trial information, it's important to note that all medications can have potential side effects. In clinical trials, researchers closely monitor participants for any adverse reactions to ensure patient safety.

Ongoing Clinical Trials on Azithromycin Dihydrate

  • Study of Azithromycin Treatment Based on Mucus Changes in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    2 1 1 1
    Investigated drugs:
    France

  • Using a drug combination to treat vaginal flora abnormalities in pregnant women at high risk of preterm birth.

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Azithromycin, Doxycycline, and Sodium Ascorbate for Patients with Early-Stage Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

Glossary

  • Azithromycin Dihydrate: An antibiotic medication belonging to the macrolide class, used to treat various bacterial infections and studied for its potential benefits in different medical conditions.
  • Bronchiolitis Obliterans Syndrome (BOS): A form of chronic lung allograft dysfunction characterized by progressive airflow obstruction after lung transplantation.
  • Lymphocytic Bronchiolitis: An inflammatory condition of the small airways in the lungs, often seen as a complication after lung transplantation.
  • Bioequivalence: The property of two drug products having the same biological effect and availability in the body when administered under similar conditions.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Anti-TNF Agents: Medications that block tumor necrosis factor (TNF), used to treat inflammatory conditions such as Crohn's disease.
  • Immunogenicity: The ability of a substance to provoke an immune response in the body, which can sometimes lead to the development of antibodies against medications.
  • Bronchoalveolar Lavage (BAL): A medical procedure in which a small part of the lung is washed with fluid to collect cells and other substances for examination.
  • Forced Expiratory Volume in One Second (FEV1): A measure of lung function that represents the volume of air a person can forcefully exhale in one second.
  • C-reactive Protein (CRP): A protein produced by the liver in response to inflammation, often used as a marker of inflammation in the body.

References

  1. https://clinicaltrials.gov/study/NCT03353480
  2. https://clinicaltrials.gov/study/NCT01109160
  3. https://clinicaltrials.gov/study/NCT03199547
  4. https://clinicaltrials.gov/study/NCT04669717
  5. https://clinicaltrials.gov/study/NCT06584474
  6. https://clinicaltrials.gov/study/NCT05437783
  7. https://clinicaltrials.gov/study/NCT04347512